Subscribe
Pneumonia
Can pneumonia vaccines prevent mycoplasma pneumonia?
There are currently two types of pneumonia vaccines available domestically: the 23-valent polysaccharide vaccine and the 7-valent or 13-valent vaccines. These vaccines primarily prevent infections caused by certain serotypes of Streptococcus pneumoniae. The pneumonia vaccines cannot prevent Mycoplasma pneumonia, as Mycoplasma and Streptococcus pneumoniae are two different types of pathogens and do not share the same antibodies for protective effects. Thus, the pneumonia vaccines are mainly for preventing diseases related to Streptococcus pneumoniae infections, and are ineffective against Mycoplasma pneumonia.
Can pneumonia be cured?
Can pneumonia be cured, and will there be any sequelae? Generally speaking, common pneumonia without complications can be completely cured. If pneumonia infection is detected, seek medical attention in a timely manner and treat it rationally under the guidance of a professional doctor, it generally will not leave sequelae or affect lung function. However, some complications of pneumonia, such as meningitis and pericarditis, may leave symptoms like headaches, dizziness, palpitations, and chest pain. Ordinary pneumonia might leave streaky shadows or irregular pleura on chest X-rays or lung CT scans, but these will not impact the human body. Patients who have previously been infected with tuberculosis may have calcification spots in their lungs, which is a normal phenomenon. Some people may experience sequelae after treatment, such as hearing loss caused by the use of antimicrobial drugs, and avascular necrosis of the femoral head occurring after SARS treatment; however, these are possibly side effects of the drugs, rather than sequelae of pneumonia.
How many shots are in the pneumonia vaccine?
Currently, there are two general types of vaccines for preventing pneumococcal pneumonia. One type is the 23-valent vaccine, suitable for high-risk populations over two years old. The other type includes the 7-valent or 13-valent vaccines, which are for preventing pneumococcal infections in infants under two years old. Infants under two usually follow a "three plus one" vaccination regimen, which involves three primary immunization doses with at least one month between each dose, followed by a booster shot. Additionally, adults over two years old or other high-risk groups are advised to take the 23-valent vaccine, which requires only a single dose. However, those who are frail or have poor immune responses may need a second booster dose five years after the initial vaccination.